Literature DB >> 21422303

Predictors of surgical and hearing long-term results for inlay cartilage tympanoplasty.

Yi-Chiao Lin1, Wen-Hung Wang, Hsu-Huei Weng, Yen-Chun Lin.   

Abstract

OBJECTIVE: To determine the prognostic factors that affect surgical and audiologic outcomes in inlay tympanoplasty after long-term follow-up.
DESIGN: Case series study.
SETTING: Tertiary referral center. PATIENTS: Sixty-two patients who underwent 71 procedures were enrolled in the study. Patient ages ranged from 31 to 87 years (mean [SD] age, 61.2 [12.9] years). Mean (SD) follow-up was 635.7 (284.7) days. The inclusion criteria were (1) inlay cartilage tympanoplasty performed using local anesthesia via a transcanal route, (2) chronic otitis media with stable perforation, and (3) dry ear without middle ear disease. MAIN OUTCOME MEASURES: The success rate and hearing change at the last follow-up visit.
RESULTS: The overall success rate was 87.3% at the last visit. Using multivariate analysis, sex, age, size of perforation, side of perforation, and the presence of diabetes mellitus and external auditory canal otomycosis did not affect the success. Smoking was the only independent factor for the prognosis of surgical outcome (odds ratio [OR], 8.16; 95% confidence interval [CI], 1.74-36.89; P < .006). On the other hand, age (OR, 6.62; 95% CI, 1.13-38.47; P = .03) and perforation size (OR, 0.11; 95% CI, 0.10-0.79; P = .03) were independent factors for the prognosis of audiologic outcomes.
CONCLUSIONS: The frequency of failure was significantly higher for smokers than for nonsmokers. To quit smoking is highly recommended preoperatively for individuals scheduled for chronic otitis media inlay tympanoplasty intervention. Younger patients and those with larger perforations (>50%) were more likely to benefit from this operation.

Entities:  

Mesh:

Year:  2011        PMID: 21422303     DOI: 10.1001/archoto.2011.10

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Serum cotinine levels should optimally be measured when evaluating the outcomes of cartilage tympanoplasty in smokers.

Authors:  Xudan Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-04       Impact factor: 2.503

2.  A Prospective Study on Middle Ear Risk Index (MERI) and Outcome of Tympanoplasty with a Note on quality-of-Life (QOL).

Authors:  Lakshmi Shree Nallapaneni; Shyam Sudhakar Sudarsan; Srinivasan Krishnamoorthy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-31

Review 3.  Success rates for various graft materials in tympanoplasty - A review.

Authors:  Ali Bayram; Nuray Bayar Muluk; Cemal Cingi; Sameer Ali Bafaqeeh
Journal:  J Otol       Date:  2020-01-07

4.  Cartilage tympanoplasty: a reliable technique for smokers.

Authors:  E Kyrodimos; G A Stamatiou; E Margaritis; D Kikidis; A Sismanis
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-26       Impact factor: 2.503

5.  Comparison of Short- and Long-term Hearing Outcomes of Successful Inlay Cartilage Tympanoplasty Between Small and Large Eardrum Perforations.

Authors:  Pei-Wen Wu; Wen-Hung Wang; Chi-Che Huang; Ta-Jen Lee; Chien-Chia Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-11-10       Impact factor: 3.372

6.  Comparison of Grafting Success Rate and Hearing Outcomes between Primary and Revision Tympanoplasties.

Authors:  Mohammad Faramarzi; Mahmood Shishegar; Saeed Reza Tofighi; Hadi Sharouny; Raman Rajagopalan
Journal:  Iran J Otorhinolaryngol       Date:  2019-01

7.  Long Term Versus Short Term Hearing Results in Endoscopic Sandwich Myringoplasty.

Authors:  Bikash Lal Shrestha; Ashish Dhakal; Akash Pradhan; Monika Pokharel; Pradeep Rajbhandari; Abha Kiran Kc; Krishna Sunadar Shrestha
Journal:  Iran J Otorhinolaryngol       Date:  2021-09

8.  Developing a novel meatal areolar tissue autograft for minimally invasive tympanoplasty.

Authors:  Yen-Chi Chen; Chii-Yuan Huang; Ying-Ju Kuo; Hsiu-Lien Cheng; Yen-Fu Cheng; Wen Huei Liao
Journal:  J Chin Med Assoc       Date:  2020-10       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.